|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo M, Wang M, Deng H, Zhang X and Wang
Z-Y: A novel anticancer agent Broussoflavonol B downregulates
estrogen receptor (ER)-α36 expression and inhibits growth of
ER-negative breast cancer MDA-MB-231 cells. Eur J Pharmacol.
714:56–64. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Munoz J, Wheler J and Kurzrock R:
Expression of estrogen and progesterone receptors across human
malignancies: New therapeutic opportunities. Cancer Metastasis Rev.
Dec 28–2014.Epub ahead of print. PubMed/NCBI
|
|
4
|
Masuda H, Zhang D, Bartholomeusz C,
Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth
factor receptor in breast cancer. Breast Cancer Res Treat.
136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dawood S, Broglio K, Buzdar AU, Hortobagyi
GN and Giordano SH: Prognosis of women with metastatic breast
cancer by HER2 status and trastuzumab treatment: An
institutional-based review. J Clin Oncol. 28:92–98. 2010.
View Article : Google Scholar :
|
|
6
|
Bourboulia D and Stetler-Stevenson WG:
Matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs): Positive and negative regulators in
tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stetler-Stevenson WG: Tissue inhibitors of
metalloproteinases in cell signaling: Metalloproteinase-independent
biological activities. Sci Signal. 1:re62008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vandenbroucke RE and Libert C: Is there
new hope for therapeutic matrix metalloproteinase inhibition? Nat
Rev Drug Discov. 13:904–927. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hadler-Olsen E, Winberg J-O and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oyagbemi AA, Saba AB and Azeez OI:
Molecular targets of [6]-gingerol: Its potential roles in cancer
chemoprevention. Biofactors. 36:169–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shukla Y and Singh M: Cancer preventive
properties of ginger: A brief review. Food Chem Toxicol.
45:683–690. 2007. View Article : Google Scholar
|
|
13
|
Baliga MS, Haniadka R, Pereira MM, D'Souza
JJ, Pallaty PL, Bhat HP and Popuri S: Update on the chemopreventive
effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr.
51:499–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee T-Y, Lee K-C, Chen S-Y and Chang H-H:
6-Gingerol inhibits ROS and iNOS through the suppression of PKC-α
and NF-kappaB pathways in lipopolysaccharide-stimulated mouse
macrophages. Biochem Biophys Res Commun. 382:134–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee HS, Seo EY, Kang NE and Kim WK:
[6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer
cells. J Nutr Biochem. 19:313–319. 2008. View Article : Google Scholar
|
|
16
|
Lee S-H, Cekanova M and Baek SJ: Multiple
mechanisms are involved in 6-gingerol-induced cell growth arrest
and apoptosis in human colorectal cancer cells. Mol Carcinog.
47:197–208. 2008. View
Article : Google Scholar :
|
|
17
|
Brown AC, Shah C, Liu J, Pham JTH, Zhang
JG and Jadus MR: Ginger's (Zingiber officinale Roscoe) inhibition
of rat colonic adenocarcinoma cells proliferation and angiogenesis
in vitro. Phytother Res. 23:640–645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weng C-J, Wu C-F, Huang H-W, Ho C-T and
Yen G-C: Anti-invasion effects of 6-shogaol and 6-gingerol, two
active components in ginger, on human hepatocarcinoma cells. Mol
Nutr Food Res. 54:1618–1627. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim MO, Lee M-H, Oi N, Kim SH, Bae KB,
Huang Z, Kim DJ, Reddy K, Lee SY, Park SJ, et al: [6]-shogaol
inhibits growth and induces apoptosis of non-small cell lung cancer
cells by directly regulating Akt1/2. Carcinogenesis. 35:683–691.
2014. View Article : Google Scholar :
|
|
20
|
Fan J, Yang X and Bi Z: 6-Gingerol
inhibits osteosarcoma cell proliferation through apoptosis and AMPK
activation. Tumour Biol. 36:1135–1141. 2015. View Article : Google Scholar
|
|
21
|
Kim JS, Lee SI, Park HW, Yang JH, Shin TY,
Kim YC, Baek NI, Kim SH, Choi SU, Kwon BM, et al: Cytotoxic
components from the dried rhizomes of Zingiber officinale Roscoe.
Arch Pharm Res. 31:415–418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sang S, Hong J, Wu H, Liu J, Yang CS, Pan
MH, Badmaev V and Ho CT: Increased growth inhibitory effects on
human cancer cells and anti-inflammatory potency of shogaols from
Zingiber officinale relative to gingerols. J Agric Food Chem.
57:10645–10650. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho Y-R, Choi SW and Seo D-W: The in vitro
antitumor activity of Siegesbeckia glabrescens against ovarian
cancer through suppression of receptor tyrosine kinase expression
and the signaling pathways. Oncol Rep. 30:221–226. 2013.PubMed/NCBI
|
|
24
|
Kim H-J, Ko H-Y, Choi S-W and Seo D-W:
Anti-angiogenic effects of Siegesbeckia glabrescens are mediated by
suppression of the Akt and p70S6K-dependent signaling pathways.
Oncol Rep. 33:699–704. 2015.
|
|
25
|
Lee HN, Kim J-K, Kim JH, Lee SJ, Ahn EK,
Oh JS and Seo DW: A mechanistic study on the anti-cancer activity
of ethyl caffeate in human ovarian cancer SKOV-3 cells. Chem Biol
Interact. 219:151–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SH, Cho Y-R, Kim H-J, Oh JS, Ahn EK,
Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, et al: Antagonism of
VEGF-A-induced increase in vascular permeability by an integrin
α3β1-Shp-1-cAMP/PKA pathway. Blood. 120:4892–4902. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim H-J, Cho Y-R, Kim SH and Seo D-W:
TIMP-2-derived 18-mer peptide inhibits endothelial cell
proliferation and migration through cAMP/PKA-dependent mechanism.
Cancer Lett. 343:210–216. 2014. View Article : Google Scholar
|
|
28
|
Lee HN, Joo J-H, Oh JS, Choi SW and Seo
D-W: Regulatory effects of Siegesbeckia glabrescens on non-small
cell lung cancer cell proliferation and invasion. Am J Chin Med.
42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoon HJ, Cho Y-R, Joo J-H and Seo D-W:
Knockdown of integrin α3β1 expression induces proliferation and
migration of non-small cell lung cancer cells. Oncol Rep.
29:662–668. 2013.
|
|
30
|
Cho Y-R, Kim JH, Kim J-K, Ahn EK, Ko HJ,
In JK, Lee SJ, Bae U, Kim YK, Oh JS, et al: Broussonetia kazinoki
modulates the expression of VEGFR-2 and MMP-2 through the
inhibition of ERK, Akt and p70S6K dependent signaling pathways: Its
implication in endothelial cell proliferation, migration and
tubular formation. Oncol Rep. 32:1531–1536. 2014.PubMed/NCBI
|
|
31
|
Jamdade VS, Sethi N, Mundhe NA, Kumar P,
Lahkar M and Sinha N: Therapeutic targets of triple-negative breast
cancer: A review. Br J Pharmacol. 172:4228–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ali BH, Blunden G, Tanira MO and Nemmar A:
Some phyto-chemical, pharmacological and toxicological properties
of ginger (Zingiber officinale Roscoe): A review of recent
research. Food Chem Toxicol. 46:409–420. 2008. View Article : Google Scholar
|
|
33
|
Weng C-J, Chou C-P, Ho C-T and Yen G-C:
Molecular mechanism inhibiting human hepatocarcinoma cell invasion
by 6-shogaol and 6-gingerol. Mol Nutr Food Res. 56:1304–1314. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Seo D-W, Li H, Guedez L, Wingfield PT,
Diaz T, Salloum R, Wei BY and Stetler-Stevenson WG: TIMP-2 mediated
inhibition of angiogenesis: An MMP-independent mechanism. Cell.
114:171–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burness ML, Grushko TA and Olopade OI:
Epidermal growth factor receptor in triple-negative and basal-like
breast cancer: Promising clinical target or only a marker? Cancer
J. 16:23–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
